THERAVANCE BIOPHARMA R & D IP LLC has a total of 63 patent applications. Its first patent ever was published in 2003. It filed its patents most often in EPO (European Patent Office), South Africa and China. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are JANSSEN R & D IRELAND, INST HEPATITIS & VIRUS RES and FAB PHARMA SAS.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 10 | |
#2 | South Africa | 10 | |
#3 | China | 6 | |
#4 | Japan | 6 | |
#5 | New Zealand | 6 | |
#6 | Canada | 4 | |
#7 | Malaysia | 4 | |
#8 | Hong Kong | 3 | |
#9 | Israel | 3 | |
#10 | WIPO (World Intellectual Property Organization) | 3 | |
#11 | Brazil | 2 | |
#12 | Republic of Korea | 2 | |
#13 | Singapore | 2 | |
#14 | Taiwan | 1 | |
#15 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Fleury Melissa | 18 |
#2 | Hughes Adam D | 13 |
#3 | Gendron Roland | 12 |
#4 | Hughes Adam | 10 |
#5 | Long Daniel D | 9 |
#6 | Mckinnell Robert Murray | 7 |
#7 | Fatheree Paul R | 7 |
#8 | Stangeland Eric L | 7 |
#9 | Rapta Miroslav | 6 |
#10 | Colson Pierre-Jean | 6 |
Publication | Filing date | Title |
---|---|---|
CN104350052A | Nitric oxide donor neprilysin inhibitors | |
NZ611528A | Neprilysin inhibitors | |
EP2560646A2 | Combination of a serotonin and norepinephrine reuptake inhibitor and an opioid agonist for the treatment of pain | |
EP2550252A1 | 1-(2-phenoxymethylheteroaryl)piperidine and piperazine compounds | |
EP2453894A1 | Crystalline freebase form of a biphenyl compound |